112 related articles for article (PubMed ID: 17518630)
41. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering.
Appleton AJ; Appleton CT; Boughner DR; Rogers KA
Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261
[TBL] [Abstract][Full Text] [Related]
42. Development of human umbilical vein endothelial cell (HUVEC) and human umbilical vein smooth muscle cell (HUVSMC) branch/stem structures on hydrogel layers via biological laser printing (BioLP).
Wu PK; Ringeisen BR
Biofabrication; 2010 Mar; 2(1):014111. PubMed ID: 20811126
[TBL] [Abstract][Full Text] [Related]
43. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
[TBL] [Abstract][Full Text] [Related]
44. A modular tissue engineering construct containing smooth muscle cells and endothelial cells.
Leung BM; Sefton MV
Ann Biomed Eng; 2007 Dec; 35(12):2039-49. PubMed ID: 17882548
[TBL] [Abstract][Full Text] [Related]
45. Behavior of human mesenchymal stem cells in fibrin-based vascular tissue engineering constructs.
O'Cearbhaill ED; Murphy M; Barry F; McHugh PE; Barron V
Ann Biomed Eng; 2010 Mar; 38(3):649-57. PubMed ID: 20077010
[TBL] [Abstract][Full Text] [Related]
46. Cell electrospinning highly concentrated cellular suspensions containing primary living organisms into cell-bearing threads and scaffolds.
Jayasinghe SN; Irvine S; McEwan JR
Nanomedicine (Lond); 2007 Aug; 2(4):555-67. PubMed ID: 17716138
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-10 controls the protective effects of circulating microparticles from patients with septic shock on tissue-engineered vascular media.
Mostefai HA; Bourget JM; Meziani F; Martinez MC; Leonetti D; Mercat A; Asfar P; Germain L; Andriantsitohaina R
Clin Sci (Lond); 2013 Jul; 125(2):77-85. PubMed ID: 23379624
[TBL] [Abstract][Full Text] [Related]
48. Effects of cyclic stretch on proliferation of mesenchymal stem cells and their differentiation to smooth muscle cells.
Ghazanfari S; Tafazzoli-Shadpour M; Shokrgozar MA
Biochem Biophys Res Commun; 2009 Oct; 388(3):601-5. PubMed ID: 19695226
[TBL] [Abstract][Full Text] [Related]
49. Age effects on vascular smooth muscle: an engineered tissue approach.
Solan A; Niklason L
Cell Transplant; 2005; 14(7):481-8. PubMed ID: 16285256
[TBL] [Abstract][Full Text] [Related]
50. Smooth muscle-like tissue constructs with circumferentially oriented cells formed by the cell fiber technology.
Hsiao AY; Okitsu T; Onoe H; Kiyosawa M; Teramae H; Iwanaga S; Kazama T; Matsumoto T; Takeuchi S
PLoS One; 2015; 10(3):e0119010. PubMed ID: 25734774
[TBL] [Abstract][Full Text] [Related]
51. Time-dependent modulation of alignment and differentiation of smooth muscle cells seeded on a porous substrate undergoing cyclic mechanical strain.
Cha JM; Park SN; Noh SH; Suh H
Artif Organs; 2006 Apr; 30(4):250-8. PubMed ID: 16643383
[TBL] [Abstract][Full Text] [Related]
52. Engineered small diameter vascular grafts by combining cell sheet engineering and electrospinning technology.
Ahn H; Ju YM; Takahashi H; Williams DF; Yoo JJ; Lee SJ; Okano T; Atala A
Acta Biomater; 2015 Apr; 16():14-22. PubMed ID: 25641646
[TBL] [Abstract][Full Text] [Related]
53. Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering.
Xu C; Inai R; Kotaki M; Ramakrishna S
Tissue Eng; 2004; 10(7-8):1160-8. PubMed ID: 15363172
[TBL] [Abstract][Full Text] [Related]
54. Vascular smooth muscle cells on hyaluronic acid: culture and mechanical characterization of an engineered vascular construct.
Remuzzi A; Mantero S; Colombo M; Morigi M; Binda E; Camozzi D; Imberti B
Tissue Eng; 2004; 10(5-6):699-710. PubMed ID: 15265287
[TBL] [Abstract][Full Text] [Related]
55. Experimental models that mimic the differentiation and dedifferentiation of vascular cells.
Pauly RR; Passaniti A; Crow M; Kinsella JL; Papadopoulos N; Monticone R; Lakatta EG; Martin GR
Circulation; 1992 Dec; 86(6 Suppl):III68-73. PubMed ID: 1330366
[TBL] [Abstract][Full Text] [Related]
56. Freeze-thaw induced biomechanical changes in arteries: role of collagen matrix and smooth muscle cells.
Venkatasubramanian RT; Wolkers WF; Shenoi MM; Barocas VH; Lafontaine D; Soule CL; Iaizzo PA; Bischof JC
Ann Biomed Eng; 2010 Mar; 38(3):694-706. PubMed ID: 20108044
[TBL] [Abstract][Full Text] [Related]
57. Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migration.
Shimizu-Hirota R; Sasamura H; Kuroda M; Kobayashi E; Hayashi M; Saruta T
Circ Res; 2004 Apr; 94(8):1067-74. PubMed ID: 15031262
[TBL] [Abstract][Full Text] [Related]
58. Perfusion bioreactor for small diameter tissue-engineered arteries.
Williams C; Wick TM
Tissue Eng; 2004; 10(5-6):930-41. PubMed ID: 15265311
[TBL] [Abstract][Full Text] [Related]
59. Modulation of vascular smooth muscle cells proteoglycan synthesis by the extracellular matrix.
Figueroa JE; Oubre J; Vijayagopal P
J Cell Physiol; 2004 Feb; 198(2):302-9. PubMed ID: 14603532
[TBL] [Abstract][Full Text] [Related]
60. Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors.
Jeong SI; Kim SY; Cho SK; Chong MS; Kim KS; Kim H; Lee SB; Lee YM
Biomaterials; 2007 Feb; 28(6):1115-22. PubMed ID: 17112581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
